409 results on '"Nakano, Ichiro"'
Search Results
2. IMMU-55. THERAPEUTIC WINDOW ENABLING ERADICATION OF RESIDUAL GLIOMA STEM CELLS BY INTRACRANIAL NK CELL AND EXTRACELLULAR VESICLE-MEDIATED THERAPY FOLLOWING TEMOZOLOMIDE-INDUCED TUMOUR DEPOPULATION
3. Proteomic analysis reveals microvesicles containing NAMPT as mediators of radioresistance in glioma
4. Data from The AMPK Inhibitor Compound C Is a Potent AMPK-Independent Antiglioma Agent
5. Data from Identification of ALDH1A3 as a Viable Therapeutic Target in Breast Cancer Metastasis–Initiating Cells
6. Data from Differential Response of Glioma Stem Cells to Arsenic Trioxide Therapy Is Regulated by MNK1 and mRNA Translation
7. Data from A Molecular Screening Approach to Identify and Characterize Inhibitors of Glioblastoma Stem Cells
8. Supplementary Figures S1 - S2 from Differential Response of Glioma Stem Cells to Arsenic Trioxide Therapy Is Regulated by MNK1 and mRNA Translation
9. Supplementary Methods from Differential Response of Glioma Stem Cells to Arsenic Trioxide Therapy Is Regulated by MNK1 and mRNA Translation
10. Supplementary Table S1 from Differential Response of Glioma Stem Cells to Arsenic Trioxide Therapy Is Regulated by MNK1 and mRNA Translation
11. Supplementary Figure 3 from Identification of ALDH1A3 as a Viable Therapeutic Target in Breast Cancer Metastasis–Initiating Cells
12. Supplementary Figure 2 from A Molecular Screening Approach to Identify and Characterize Inhibitors of Glioblastoma Stem Cells
13. Supplementary Figure 1 from Identification of ALDH1A3 as a Viable Therapeutic Target in Breast Cancer Metastasis–Initiating Cells
14. Supplementary Figure 3 from A Molecular Screening Approach to Identify and Characterize Inhibitors of Glioblastoma Stem Cells
15. Supplementary Table 3 from A Molecular Screening Approach to Identify and Characterize Inhibitors of Glioblastoma Stem Cells
16. Supplementary Table S2 from Differential Response of Glioma Stem Cells to Arsenic Trioxide Therapy Is Regulated by MNK1 and mRNA Translation
17. Supplementary Figures 1 - 4 from The AMPK Inhibitor Compound C Is a Potent AMPK-Independent Antiglioma Agent
18. Data from Identification of ALDH1A3 as a Viable Therapeutic Target in Breast Cancer Metastasis–Initiating Cells
19. Supplementary Figure 2 from Identification of ALDH1A3 as a Viable Therapeutic Target in Breast Cancer Metastasis–Initiating Cells
20. Supplementary Figure 6 from Identification of ALDH1A3 as a Viable Therapeutic Target in Breast Cancer Metastasis–Initiating Cells
21. Data from Differential Response of Glioma Stem Cells to Arsenic Trioxide Therapy Is Regulated by MNK1 and mRNA Translation
22. Supplementary Figure 1 from MNK Inhibition Disrupts Mesenchymal Glioma Stem Cells and Prolongs Survival in a Mouse Model of Glioblastoma
23. Data from MNK Inhibition Disrupts Mesenchymal Glioma Stem Cells and Prolongs Survival in a Mouse Model of Glioblastoma
24. Supplementary Figure 2 from A Molecular Screening Approach to Identify and Characterize Inhibitors of Glioblastoma Stem Cells
25. Table S3 from Identification of ALDH1A3 as a Viable Therapeutic Target in Breast Cancer Metastasis–Initiating Cells
26. Data from MNK Inhibition Disrupts Mesenchymal Glioma Stem Cells and Prolongs Survival in a Mouse Model of Glioblastoma
27. Supplementary Table 1 from A Molecular Screening Approach to Identify and Characterize Inhibitors of Glioblastoma Stem Cells
28. Supplementary Figure 5 from Identification of ALDH1A3 as a Viable Therapeutic Target in Breast Cancer Metastasis–Initiating Cells
29. Data from A Molecular Screening Approach to Identify and Characterize Inhibitors of Glioblastoma Stem Cells
30. Supplementary Figure 5 from Identification of ALDH1A3 as a Viable Therapeutic Target in Breast Cancer Metastasis–Initiating Cells
31. Supplementary Figure 1 from A Molecular Screening Approach to Identify and Characterize Inhibitors of Glioblastoma Stem Cells
32. Table S3 from Identification of ALDH1A3 as a Viable Therapeutic Target in Breast Cancer Metastasis–Initiating Cells
33. Table S1 from Identification of ALDH1A3 as a Viable Therapeutic Target in Breast Cancer Metastasis–Initiating Cells
34. Supplementary Figure 6 from Identification of ALDH1A3 as a Viable Therapeutic Target in Breast Cancer Metastasis–Initiating Cells
35. Supplementary Figure 5 from A Molecular Screening Approach to Identify and Characterize Inhibitors of Glioblastoma Stem Cells
36. Supplementary Table 2 from A Molecular Screening Approach to Identify and Characterize Inhibitors of Glioblastoma Stem Cells
37. Supplementary Figure 7 from A Molecular Screening Approach to Identify and Characterize Inhibitors of Glioblastoma Stem Cells
38. Supplementary Figure 3 from A Molecular Screening Approach to Identify and Characterize Inhibitors of Glioblastoma Stem Cells
39. Supplementary Figure 6 from A Molecular Screening Approach to Identify and Characterize Inhibitors of Glioblastoma Stem Cells
40. Supplementary Table 1 from A Molecular Screening Approach to Identify and Characterize Inhibitors of Glioblastoma Stem Cells
41. Supplementary Figure 4 from A Molecular Screening Approach to Identify and Characterize Inhibitors of Glioblastoma Stem Cells
42. Supplementary Figure 7 from A Molecular Screening Approach to Identify and Characterize Inhibitors of Glioblastoma Stem Cells
43. Figure S1-S4 from Perhexiline Demonstrates FYN-mediated Antitumor Activity in Glioblastoma
44. Supplementary Figure 4 from Identification of ALDH1A3 as a Viable Therapeutic Target in Breast Cancer Metastasis–Initiating Cells
45. Figure S1-S4 from Perhexiline Demonstrates FYN-mediated Antitumor Activity in Glioblastoma
46. Supplementary Figure 1 from A Molecular Screening Approach to Identify and Characterize Inhibitors of Glioblastoma Stem Cells
47. Supplementary Figure 3 from Identification of ALDH1A3 as a Viable Therapeutic Target in Breast Cancer Metastasis–Initiating Cells
48. Supplementary Figure 8 from Identification of ALDH1A3 as a Viable Therapeutic Target in Breast Cancer Metastasis–Initiating Cells
49. Table S2 from Identification of ALDH1A3 as a Viable Therapeutic Target in Breast Cancer Metastasis–Initiating Cells
50. Supplementary Figure 4 from A Molecular Screening Approach to Identify and Characterize Inhibitors of Glioblastoma Stem Cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.